Design and Synthesis of (3‐Phenylisoxazol‐5‐yl)methanimine Derivatives as Hepatitis B Virus Inhibitors
Chemistry & Biodiversity · 2023
DOI: 10.1002/cbdv.202201247 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2023. Verfasst von Zhengcheng Liang und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Chemical Engineering, Guangxi University, 530004, Nanning, China. Hauptthemen laut MEDLINE: Hepatitis B virus, Herpesvirus 1, Cercopithecine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Series of (3‐phenylisoxazol‐5‐yl)methanimine derivatives were synthesized, and evaluated for anti‐hepatitis B virus (HBV) activity in vitro. Half of them more effectively inhibited HBsAg than 3TC, and more favor to inhibit secretion of HBeAg than to HBsAg. Part of the compounds with significant inhibition on HBeAg were also effectively inhibit replication of HBV DNA. Compound ( E )‐3‐(4‐fluorophenyl)‐5‐((2‐phenylhydrazineylidene)methyl)isoxazole inhibited excellently HBeAg with IC 50 in 0.65 μM (3TC(Lamivudine) in 189.90 μM), inhibited HBV DNA in 20.52 μM (3TC in 26.23 μM). Structures of compounds were determined by NMR and HRMS methods, and chlorination on phenyl ring of phenylisoxazol‐5‐yl was confirmed by X‐ray diffraction analysis, and the structure–activity relationships (SARs) of the derivatives was discussed. This work provided a new class of potent non‐nucleoside anti‐HBV agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemistry and Chemical Engineering, Guangxi University, 530004, Nanning, China.
- College of Life Sciences, Guangxi University, 530004, Nanning, China.
- Guangxi Center for Animal Disease Control and Prevention, 530001, Nanning, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liang, Z., Tan, Y., Huang, Y., Liang, T., Wei, W., Wang, M., & Shi, K. (2023). Design and Synthesis of (3‐Phenylisoxazol‐5‐yl)methanimine Derivatives as Hepatitis B Virus Inhibitors. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202201247
Vancouver
Liang Z, Tan Y, Huang Y, Liang T, Wei W, Wang M, et al. Design and Synthesis of (3‐Phenylisoxazol‐5‐yl)methanimine Derivatives as Hepatitis B Virus Inhibitors. Chemistry & Biodiversity. 2023. doi:10.1002/cbdv.202201247
BibTeX
@article{Liang2023,
author = {Liang, Zhengcheng and Tan, Yongqing and Huang, Yunhou and Liang, Taoyuan and Wei, Wanxing and Wang, Mian and Shi, Kaichuang},
title = {Design and Synthesis of (3‐Phenylisoxazol‐5‐yl)methanimine Derivatives as Hepatitis B Virus Inhibitors},
journal = {Chemistry & Biodiversity},
year = {2023},
doi = {10.1002/cbdv.202201247}
}
EUVIMED